Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Ensign Group (ENSG) Buys Nursing Facility to Expand in Arizona

Published 01/06/2022, 05:27 AM
Updated 07/09/2023, 06:31 AM

The Ensign Group (NASDAQ:ENSG), Inc. ENSG recently purchased operations of Estrella Health and Rehabilitation Center, a 161-bed skilled nursing facility in Avondale, AZ. Subject to a long-term triple net lease, the buyout was effective Jan 1, 2022.

This latest move will help it solidify its presence in the Arizona region. Holding a strong growth potential, the newly-acquired facility will add credibility to ENSG’s operations.

With this latest addition, Ensign Group’s portfolio now stands at 246 healthcare operations, of which 22 include senior living operations across 13 states. Management reassured that the nursing home company is looking for opportunities to acquire real estate and lease well-performing and struggling skilled nursing, senior living and other healthcare-related businesses throughout the United States. This highlights its intention to sustain the momentum.

Acquisition Story

Ensign Group is aggressive about acquiring real estate or leasing strongly performing as well as struggling post-acute care operations and subsequently, evolving those into market leaders.

In November 2021, this major player in skilled nursing facility purchased the real-estate properties of five skilled nursing and assisted living facilities across Arizona, California or Kansas. Last year, ENSG bought Sedona Trace Health and Wellness Center in Austin TX, and Cedar Pointe Health and Wellness Center in Cedar TX besides four skilled nursing facilities and their operations in Washington.

The buyout strategy of Ensign Group is focused on identifying opportunistic and strategic buyouts that lie within specific markets and deliver robust returns. ENSG leaves no stone unturned when it comes to boosting its portfolio through inorganic growth.

Over the period starting Jan 1, 2010 until Dec 31, 2020, ENSG acquired 205 facilities. This buyout binge helps the leading industry player establish its dominance further in the United States.

Like ENSG, other medical stocks serious about their M&A strategy include Encompass Health (NYSE:EHC) Corporation EHC, HCA Healthcare (NYSE:HCA), Inc. HCA and Tenet Healthcare Corporation (NYSE:THC) THC.

Encompass Health focuses on expansion plans to add inpatient rehabilitation hospitals to its existing network and build scale in hospice. In June 2021, EHC purchased the home health and hospice assets of Frontier Home Health and Hospice across Alaska, Colorado, Montana, Washington and Wyoming.

HCA Healthcare is committed to undertaking acquisitions, which have so far added and expanded facilities across several markets as well as increased patient volumes. HCA spends a substantial amount on acquiring hospitals and health care entities, which induced expenses of $488 million in the first nine months of 2021. HCA recently purchased MD Now Urgent Care from an LA-based private equity investment firm, Brentwood Associates.

Tenet Healthcare pursued numerous acquisitions, partnerships and strategic alliances to expand the scale of business, operating capacity and geographical presence. In November 2021, THC along with its unit United Surgical Partners International (USPI) entered into a definitive agreement to acquire SurgCenter Development (SCD) for $1.2 billion. Its inorganic growth strategies poise it well for long-term growth.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks Rank & Price Performance

Shares of this presently Zacks Rank #3 (Hold) healthcare provider have lost 6.3% in the past six months, narrower than the industry’s decline of 14.2%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

However, its inorganic growth measures, strong underwriting results and efficient capital deployment should help the stock bounce back going forward.

Image Source: Zacks Investment Research


Zacks Top 10 Stocks for 2022

In addition to the investment ideas discussed above, would you like to know about our 10 top picks for the entirety of 2022?

From inception in 2012 through November, the Zacks Top 10 Stocks gained an impressive +962.5% versus the S&P 500’s +329.4%. Now our Director of Research is combing through 4,000 companies covered by the Zacks Rank to handpick the best 10 tickers to buy and hold. Don’t miss your chance to get in on these stocks when they’re released on January 3.

Be First To New Top 10 Stocks >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Tenet Healthcare Corporation (THC): Free Stock Analysis Report

HCA Healthcare, Inc. (HCA): Free Stock Analysis Report

The Ensign Group, Inc. (ENSG): Free Stock Analysis Report

Encompass Health Corporation (EHC): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.